Cedric Pobel, MD, covers the PEACE-1 trial of radiotherapy, standard of care, and abiraterone in low-volume metastatic castration-sensitive prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback